Sunday, December 27, 2009

Alvine Pharmaceuticals raises $21.5m for Phase 2a clinical trial to develop the 1st pharmaceutical therapy for celiac

Read More...
Related Articles: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)